+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunohistochemistry Market - Global Forecast 2026-2032- Product Image
Immunohistochemistry Market - Global Forecast 2026-2032- Product Image
New

Immunohistochemistry Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5137198
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunohistochemistry market is advancing rapidly, as laboratories and clinical leaders seek solutions that combine innovation, process efficiency, and reliable diagnostic outcomes. Senior decision-makers are prioritizing platforms and strategies that enable seamless integration of technologies, optimize operations, and build resilience across global supply networks.

Market Snapshot: Dynamics Shaping the Immunohistochemistry Market

The Immunohistochemistry Market grew from USD 3.33 billion in 2025 to USD 3.53 billion in 2026, and is forecasted to expand at a CAGR of 6.16% to reach USD 5.07 billion by 2032. Market growth is driven by rising adoption of laboratory automation, digital pathology solutions, and reagents with greater assay specificity. These developments reinforce immunohistochemistry's central role in diagnostics and translational research, with adoption increasing across both established and emerging healthcare markets. Strategic investment in infrastructure and platform reliability is enabling laboratories to meet evolving clinical demands, while technology suppliers respond with new ranges of tools and software designed for enhanced workflow efficiency.

Scope & Segmentation: Immunohistochemistry Market Analysis

This report provides a comprehensive segmentation framework with trend insights to inform strategic planning:

  • Reagent and Kit Types: Antibody classes including monoclonal, polyclonal, and recombinant formats; detection systems such as enzyme-labeled, polymer-based, and fluorophore-labeled technologies; and essential substrates, buffers, and chromogens powering routine and advanced tissue staining applications.
  • Instrumentation: Automated stainers engineered for open or closed workflows; slide imaging systems; laboratory microscopes including bright field, confocal, and fluorescence models; and laboratory automation platforms enhancing throughput and standardization.
  • Software and Services: Digital pathology and advanced image analysis software platforms; consulting, training, instrument maintenance, and assay validation services which are critical for rapid, reliable deployment of new protocols.
  • Regional Coverage: Detailed analysis for the Americas, Europe, Middle East and Africa, and Asia-Pacific markets, each with unique infrastructure maturity, regulatory requirements, and workforce capabilities shaping market dynamics.
  • Technology Drivers: Advances in multiplex assays, whole slide imaging, cloud-based data integration, and workflow interoperability facilitating scalable laboratory adoption and efficient data utilization across networks.

Key Takeaways for Senior Decision-Makers

  • Comprehensive digital pathology platforms and automation tools are transforming laboratory operations, ensuring consistent diagnostic quality, and enabling quicker interpretation of clinical cases.
  • Procurement teams increasingly value bundled reagent and instrument solutions, as well as compatibility between products from different vendors to secure validated, end-to-end laboratory performance.
  • Prioritizing standardization in pre-analytic processes and investing in robust data integration supports reproducibility and scalability, preparing laboratories for higher case volumes and evolving diagnostic needs.
  • Forming partnerships with local or regional suppliers helps mitigate risks associated with regulatory or tariff shifts and supports more predictable supply chain operations.
  • Expert-led service offerings, such as specialized consulting, validation, and user training, distinguish technology providers and accelerate the successful adoption of new immunohistochemistry systems.
  • Decisions related to antibody selection and automation infrastructure significantly influence a laboratory's operational agility, cost efficiency, and readiness for evolving regulatory standards.

Tariff Impact: Navigating U.S. Policy Changes

Recent tariff modifications in the United States have affected operational expenses and supplier strategies. Laboratories have adapted by expanding supplier portfolios, incorporating qualified domestic alternatives, and renegotiating existing agreements. These actions require robust working capital planning and have increased the focus on strategic partnerships with regional suppliers, as well as the adoption of nearshoring strategies. In turn, organizations are investing more heavily in localized quality management systems to ensure continuity and compliance in an evolving trade environment.

Methodology & Data Sources

This analysis integrates extensive primary interviews with laboratory leaders, procurement specialists, and product managers, supplemented by quantitative evidence from device registries, regulatory filings, and authoritative publications. Direct workflow observations and industry case studies provide real-world validation of key market trends. Expert review and rigorous quality controls ensure the accuracy and practical relevance of all findings.

Why This Report Matters for Stakeholders

  • Supports informed capital allocation and procurement by connecting technology trends with operational and financial outcomes relevant to stakeholders in diagnostics and research.
  • Delivers actionable guidance for manufacturers, laboratory managers, and payers aiming to enhance adoption rates, improve supply chain resilience, and uphold regulatory compliance in a dynamic environment.

Conclusion

The immunohistochemistry market is redefining clinical diagnostics and research with its movement toward integrated, validated technological solutions. Stakeholders who invest in process innovation and foster regional partnerships are well-positioned to meet the challenges of evolving clinical needs and market expansion.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Immunohistochemistry Market, by Product Category
8.1. Antibodies
8.1.1. Primary Antibodies
8.1.1.1. Monoclonal
8.1.1.1.1. Mouse
8.1.1.1.2. Rabbit
8.1.1.2. Polyclonal
8.1.1.3. Recombinant Monoclonal
8.1.1.4. Recombinant Fragments
8.1.1.4.1. scFv
8.1.1.4.2. Fab
8.1.2. Secondary Antibodies
8.1.2.1. Enzyme-Conjugated
8.1.2.2. Biotinylated
8.1.2.3. Fluorophore-Conjugated
8.1.2.4. Unconjugated
8.2. Detection Systems
8.2.1. Polymer
8.2.2. Avidin-Biotin
8.2.3. Tyramide Amplification
8.3. Chromogens & Counterstains
8.3.1. DAB
8.3.2. AEC
8.3.3. Fast Red
8.3.4. Hematoxylin
8.4. Ancillary Reagents
8.4.1. Retrieval Buffers
8.4.2. Blocking Reagents
8.4.3. Wash Buffers
8.5. Kits & Panels
8.5.1. Single-Marker Kits
8.5.2. Multiplex Panels
9. Immunohistochemistry Market, by Technology
9.1. Chromogenic IHC
9.1.1. HRP/DAB
9.1.2. AP/Red
9.1.3. Dual Enzyme
9.2. Immunofluorescence
9.2.1. Singleplex IF
9.2.2. Multiplex IF
9.2.2.1. 2-3 Plex
9.2.2.2. 4-7 Plex
9.2.2.3. 8+ Plex
9.3. Signal Amplification
9.3.1. Tyramide Signal Amplification
9.3.2. Biotin-Based Amplification
9.4. Metal-Conjugated IHC
9.4.1. Mass Cytometry-Compatible
9.4.2. MIBI-Compatible
10. Immunohistochemistry Market, by Specimen Type
10.1. FFPE Tissue
10.1.1. Resection
10.1.2. Biopsy
10.2. Frozen Tissue
10.2.1. Cryosections
10.3. Cytology Specimens
10.3.1. Smears
10.3.2. Liquid-Based Preparations
10.4. Tissue Microarrays
11. Immunohistochemistry Market, by Application
11.1. Clinical Diagnostics
11.1.1. Oncology
11.1.1.1. Solid Tumors
11.1.1.2. Hematopathology
11.1.2. Infectious Disease
11.1.3. Transplant Immunopathology
11.1.4. Neuropathology
11.1.5. Cardiovascular Pathology
11.1.6. Companion Diagnostics
11.2. Research & Drug Discovery
11.2.1. Basic Research
11.2.2. Translational Research
11.2.3. Target Validation
11.2.4. Biomarker Discovery
11.2.5. Toxicologic Pathology
11.3. Veterinary Pathology
11.4. Forensic Pathology
11.5. Education & Training
12. Immunohistochemistry Market, by Indication
12.1. Oncology
12.1.1. Breast Cancer
12.1.2. Lung Cancer
12.1.3. Colorectal Cancer
12.1.4. Prostate Cancer
12.1.5. Melanoma
12.1.6. Lymphoma
12.1.7. Brain Tumors
12.2. Infectious Diseases
12.2.1. Viral
12.2.2. Bacterial
12.2.3. Fungal
12.3. Autoimmune & Inflammatory
12.3.1. Systemic Autoimmune
12.3.2. Gastrointestinal Inflammatory
12.4. Neurological Disorders
12.4.1. Neurodegenerative
12.5. Renal & Hepatic
12.5.1. Renal Disease
12.5.2. Hepatic Disease
13. Immunohistochemistry Market, by End User
13.1. Hospital Laboratories
13.1.1. Community Hospitals
13.1.2. Academic Medical Centers
13.2. Reference Laboratories
13.3. Academic & Research Institutes
13.4. Pharmaceutical & Biotechnology
13.4.1. In-House Labs
13.4.2. Outsourced Partners
13.5. Contract Research Organizations
13.6. Veterinary Pathology Laboratories
14. Immunohistochemistry Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Immunohistochemistry Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Immunohistochemistry Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Immunohistochemistry Market
18. China Immunohistochemistry Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Abcam plc
19.7. Agilent Technologies, Inc.
19.8. Becton, Dickinson and Company
19.9. Bio-Rad Laboratories, Inc.
19.10. Biogenex Laboratories, Inc.
19.11. Cell Signaling Technology, Inc.
19.12. Danaher Corporation
19.13. Enzo Life Sciences, Inc.
19.14. F. Hoffmann-La Roche Ltd
19.15. Histo-Line Laboratories
19.16. Leica Biosystems Nussloch GmbH
19.17. Merck KGaA
19.18. Miltenyi Biotec B.V. & Co. KG
19.19. Novus Biologicals, LLC
19.20. OriGene Technologies, Inc.
19.21. PerkinElmer, Inc.
19.22. R&D Systems, Inc.
19.23. Santa Cruz Biotechnology, Inc.
19.24. Sigma-Aldrich Co. LLC
19.25. Takara Bio Inc.
19.26. Thermo Fisher Scientific Inc.
19.27. Vector Laboratories, Inc.
19.28. Wako Pure Chemical Industries, Ltd.
19.29. ZenBio, Inc.
List of Figures
FIGURE 1. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SPECIMEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MONOCLONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MONOCLONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MONOCLONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MONOCLONAL, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MOUSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MOUSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MOUSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RABBIT, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RABBIT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RABBIT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY POLYCLONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY POLYCLONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY POLYCLONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RECOMBINANT MONOCLONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RECOMBINANT MONOCLONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RECOMBINANT MONOCLONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RECOMBINANT FRAGMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RECOMBINANT FRAGMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RECOMBINANT FRAGMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RECOMBINANT FRAGMENTS, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SCFV, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SCFV, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SCFV, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ENZYME-CONJUGATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ENZYME-CONJUGATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ENZYME-CONJUGATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOTINYLATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOTINYLATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOTINYLATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FLUOROPHORE-CONJUGATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FLUOROPHORE-CONJUGATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FLUOROPHORE-CONJUGATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY UNCONJUGATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY UNCONJUGATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY UNCONJUGATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DETECTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DETECTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DETECTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DETECTION SYSTEMS, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AVIDIN-BIOTIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AVIDIN-BIOTIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AVIDIN-BIOTIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TYRAMIDE AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TYRAMIDE AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TYRAMIDE AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENS & COUNTERSTAINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENS & COUNTERSTAINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENS & COUNTERSTAINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENS & COUNTERSTAINS, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AEC, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AEC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AEC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FAST RED, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FAST RED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FAST RED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HEMATOXYLIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HEMATOXYLIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HEMATOXYLIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANCILLARY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANCILLARY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANCILLARY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANCILLARY REAGENTS, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RETRIEVAL BUFFERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RETRIEVAL BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RETRIEVAL BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY WASH BUFFERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY WASH BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY WASH BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS & PANELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS & PANELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS & PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS & PANELS, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SINGLE-MARKER KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SINGLE-MARKER KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SINGLE-MARKER KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MULTIPLEX PANELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MULTIPLEX PANELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MULTIPLEX PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC IHC, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC IHC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC IHC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC IHC, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HRP/DAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HRP/DAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HRP/DAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AP/RED, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AP/RED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AP/RED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DUAL ENZYME, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DUAL ENZYME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DUAL ENZYME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY IMMUNOFLUORESCENCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY IMMUNOFLUORESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY IMMUNOFLUORESCENCE, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SINGLEPLEX IF, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SINGLEPLEX IF, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SINGLEPLEX IF, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MULTIPLEX IF, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MULTIPLEX IF, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MULTIPLEX IF, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MULTIPLEX IF, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY 2-3 PLEX, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY 2-3 PLEX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY 2-3 PLEX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY 4-7 PLEX, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY 4-7 PLEX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY 4-7 PLEX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY 8+ PLEX, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY 8+ PLEX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY 8+ PLEX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SIGNAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SIGNAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SIGNAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SIGNAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TYRAMIDE SIGNAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TYRAMIDE SIGNAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TYRAMIDE SIGNAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOTIN-BASED AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOTIN-BASED AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOTIN-BASED AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY METAL-CONJUGATED IHC, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY METAL-CONJUGATED IHC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY METAL-CONJUGATED IHC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY METAL-CONJUGATED IHC, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MASS CYTOMETRY-COMPATIBLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MASS CYTOMETRY-COMPATIBLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MASS CYTOMETRY-COMPATIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MIBI-COMPATIBLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MIBI-COMPATIBLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MIBI-COMPATIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FFPE TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FFPE TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FFPE TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FFPE TISSUE, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RESECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RESECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FROZEN TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FROZEN TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FROZEN TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FROZEN TISSUE, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CRYOSECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CRYOSECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CRYOSECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CYTOLOGY SPECIMENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CYTOLOGY SPECIMENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CYTOLOGY SPECIMENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CYTOLOGY SPECIMENS, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SMEARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SMEARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SMEARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY LIQUID-BASED PREPARATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY LIQUID-BASED PREPARATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY LIQUID-BASED PREPARATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HEMATOPATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HEMATOPATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HEMATOPATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TRANSPLANT IMMUNOPATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TRANSPLANT IMMUNOPATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TRANSPLANT IMMUNOPATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEUROPATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEUROPATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEUROPATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RESEARCH & DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RESEARCH & DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RESEARCH & DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RESEARCH & DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BASIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 226. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 229. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TARGET VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 232. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TARGET VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 235. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TOXICOLOGIC PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TOXICOLOGIC PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 238. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TOXICOLOGIC PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY VETERINARY PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY VETERINARY PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 241. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY VETERINARY PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 242. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 243. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 244. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EDUCATION & TRAINING, BY REGION, 2018-2032 (USD MILLION)
TABLE 246. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EDUCATION & TRAINING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 247. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EDUCATION & TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 250. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 251. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 253. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 254. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 255. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 257. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 260. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 261. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 263. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 264. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MELANOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 266. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MELANOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY MELANOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 269. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY LYMPHOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 272. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 273. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 275. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 276. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 278. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 279. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 280. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 281. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 282. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 283. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 284. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FUNGAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 285. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FUNGAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 286. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FUNGAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 287. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE & INFLAMMATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 288. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE & INFLAMMATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 289. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE & INFLAMMATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 290. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE & INFLAMMATORY, 2018-2032 (USD MILLION)
TABLE 291. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SYSTEMIC AUTOIMMUNE, BY REGION, 2018-2032 (USD MILLION)
TABLE 292. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SYSTEMIC AUTOIMMUNE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 293. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SYSTEMIC AUTOIMMUNE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 294. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GASTROINTESTINAL INFLAMMATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 295. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GASTROINTESTINAL INFLAMMATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 296. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GASTROINTESTINAL INFLAMMATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 297. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 298. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 299. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 300. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 301. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEURODEGENERATIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 302. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEURODEGENERATIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 303. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEURODEGENERATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 304. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RENAL & HEPATIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 305. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RENAL & HEPATIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 306. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RENAL & HEPATIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 307. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RENAL & HEPATIC, 2018-2032 (USD MILLION)
TABLE 308. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RENAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 309. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RENAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 310. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY RENAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 311. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HEPATIC DISEASE, BY REGION, 2018-2

Companies Mentioned

The key companies profiled in this Immunohistochemistry market report include:
  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biogenex Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • Enzo Life Sciences, Inc.
  • F. Hoffmann-La Roche Ltd
  • Histo-Line Laboratories
  • Leica Biosystems Nussloch GmbH
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • Novus Biologicals, LLC
  • OriGene Technologies, Inc.
  • PerkinElmer, Inc.
  • R&D Systems, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Sigma-Aldrich Co. LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Vector Laboratories, Inc.
  • Wako Pure Chemical Industries, Ltd.
  • ZenBio, Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.53 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.07 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Immunohistochemistry Market by Product & Service (Antibodies (Type (Primary), Clonality (Monoclonal), Regulatory Class, Reagents, Kits, Instruments (Stainers), Software)), Application (Diagnostics (Cancer), Research, Forensics) - Global Forecast to 2030 - Product Image

Immunohistochemistry Market by Product & Service (Antibodies (Type (Primary), Clonality (Monoclonal), Regulatory Class, Reagents, Kits, Instruments (Stainers), Software)), Application (Diagnostics (Cancer), Research, Forensics) - Global Forecast to 2030

  • Report
  • 564 Pages
  • Global
From
Immunohistochemistry (IHC) Market Report 2025 - Product Image

Immunohistochemistry (IHC) Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Immunohistochemistry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Immunohistochemistry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End Use (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2025-2033 - Product Image

Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End Use (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Immunohistochemistry Kits & Reagents Market - Global Forecast 2025-2030 - Product Image

Immunohistochemistry Kits & Reagents Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.